Skip to main content
. 2021 Sep 15;2021:5546867. doi: 10.1155/2021/5546867

Figure 3.

Figure 3

NR inhibits NLRP3 inflammasome activation induced by TAC. (a, b) NR significantly reduced the levels of high inflammatory factors caused by myocardial hypertrophy (IL-1β: 233.17 ± 7.12 vs. 267.58 ± 10.23; TNF-α: 366.9 ± 13.40 vs. 472.9 ± 17.30, P < 0.05). (c) Western blot results showed that NR treatment significantly reduced the Caspase-1/Caspase-1 pro and cleaved GSDMD expression in TAC mice (P < 0.05). Furthermore, NR markedly reduced the NLRP3 expression in the TAC+NR group (P < 0.05). There was no significant difference in ASC expression (P > 0.05). NR: nicotinamide riboside. P < 0.05 vs. sham group; #P < 0.05 vs. TAC group.